Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 1Biosimilar and Originator Infliximab in the Hospital Setting

E Moorkens, S Simoens, P Troein, P Declerck, Arnold Vulto, I Huys

Research output: Contribution to journalArticleAcademic

22 Citations (Scopus)
3 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)285-297
Number of pages13
JournalBioDrugs
Volume33
Issue number3
DOIs
Publication statusPublished - 2019

Cite this